Desenfriol-d
NDC Package 53666-417-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Desenfriol-d is do not take more than directed (see overdose warning)adults and children 12 years and overtake 2 caplets every 4-6 hoursswallow whole – do not crush, chew or dissolvedo not take more than 10 caplets in 24 hourschildren under 12 yearsask a doctor. Marketed by Salimex, S.a., this product is identified by NDC 53666-417 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
53666-417-01
Package Description
30 BLISTER PACK in 1 BOX / .05 g in 1 BLISTER PACK
Product Code
53666-417
11-Digit Billing Format
53666041701
RxNorm Crosswalk
  • RxCUI: 1052679 - acetaminophen 500 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet
  • RxCUI: 1052679 - acetaminophen 500 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1052679 - APAP 500 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Desenfriol-d
Dosage Form
-
Usage Information
Do not take more than directed (see overdose warning)adults and children 12 years and overtake 2 caplets every 4-6 hoursswallow whole – do not crush, chew or dissolvedo not take more than 10 caplets in 24 hourschildren under 12 yearsask a doctor

Regulatory & Marketing

Labeler Name
Salimex, S.a.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
10-18-2017
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53666-417-01 identifies a specific commercial package of 30 blister pack in 1 box / .05 g in 1 blister pack of Desenfriol-d, labeled by Salimex, S.a.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Salimex, S.a. on October 18, 2017. The current certification is valid through December 31, 2021.

How is this Salimex, S.a. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53666041701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53666-417-01
11-Digit CMS (5-4-2)
53666-0417-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.